Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GBI Biomanufacturing is an established US-based biopharmaceutical CDMO with over three decades of experience in process development and cGMP-compliant manufacturing of complex biologics. The company has supported more than 150 clients across nearly 500 products at various clinical stages (Phases I–III), contributed to over 45 IND filings, and is expanding into commercial production. Its expertise includes monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates (ADCs), bioconjugates, biosimilars, and exosomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GBI Biomanufacturing.